A Comprehensive Guide to Leveraged Buyouts

Introduction

You're sizing up an acquisition built mostly with borrowed money; a leveraged buyout (LBO) is simply a purchase where the buyer funds the deal with a mix of debt and equity, commonly around 50-70% debt and 30-50% equity, so operating cash flow repays debt and amplifies returns. Typical participants are private equity sponsors (provide capital, set strategy), management (often rolls equity and runs day-to-day), and a range of lenders (banks, mezzanine, bond investors) that supply the leverage. The usual objectives are control, value creation via cost, growth or multiple expansion, and then a refinance or exit-PE targets roughly a 20-25% IRR over a 3-7 year hold. Here's the quick math: higher leverage increases equity returns if cash flows hold, but raises refinancing and covenant risk, so don't be defintely surprised if stress tests change the deal structure.

Key Takeaways

• LBOs use substantial debt (commonly ~50-70%) with equity (30-50%) so operating cash flow repays debt and amplifies equity returns; target returns are typically ~20-25% IRR over a 3-7 year hold.
• Know the capital stack and instruments-senior debt, mezzanine, sponsor/rollover equity-and the covenant and refinancing risks that drive deal viability.
• Value creation comes from three levers: operational improvements (margins, cost cuts), financial engineering (leverage, tax shields), and strategic moves (add‑ons, pricing, product mix).
• Key risks include rate/refinancing risk, operational failure and integration issues, and covenant breaches-robust stress tests and downside scenarios are essential.
• Thorough diligence (commercial, financial, legal/tax) and clear exit assumptions are decisive; use sensitivity analysis and checklists before proceeding.

Deal structure and financing

You're sizing the capital stack for an LBO and need a clear map of who gets paid first, how much equity you need, and where the risks sit. Below I break the capital stack into practical pieces, list the common financing instruments and covenants you'll meet in market, and explain how sponsor equity and management rollover work in practice.

Capital stack and allocation

Think of the capital stack as a priority ladder: senior lenders first, subordinated lenders next, and equity last. A typical mid‑market LBO in 2025 uses a mix where senior secured debt supplies most leverage, mezzanine fills gaps, and sponsor equity covers the remainder.

Typical market ranges you should plan for in 2025 are:

• Senior secured debt: 40-60% of enterprise value
• Mezzanine / subordinated debt: 0-15%
• Sponsor and rollover equity: 25-40%

Here's the quick math for a sample $500 million buyout: senior debt $275m (55%), mezzanine $50m (10%), total equity $175m (35%)-where sponsor equity might be $140m and rollover equity $35m if management keeps 20% of the equity post‑close. What this estimate hides: market appetite, company cash flow, and covenant tolerance will move each line materially, so treat these as starting defaults, not rules.

Practical steps

• Match debt seniority to cash flow stability
• Size revolver for working capital seasonality
• Limit PIK (payment‑in‑kind) to short duration deals
• Target a cushion so pro forma leverage is 0.5-1.0x below the maximum covenant level

One-liner: align debt seniority with predictability of cash flow.

Common financing instruments and covenants

Expect a blend of instruments: a revolver, one or more term loans (A/B/C structure), second‑lien debt, and occasionally mezzanine or high‑yield bonds. Pricing in 2025 commonly sits at floating rates for bank debt and fixed or higher coupon rates for subordinated debt.

• Revolver: working capital; commitment fees apply
• Term loan A: amortizing, lower margin, bank group
• Term loan B/C: longer maturity, delayed amortization, higher spread
• Second‑lien / unitranche: consolidated facility for simpler docs
• Mezzanine: subordinated notes, often with equity kicker and yields 9-16%

Standard covenants to expect and test in financial models:

• Maintenance covenants: leverage ratio (Net Debt/EBITDA) typically between 3.0-5.5x, interest coverage (EBITDA/interest) typically > 2.0-3.0x
• Incurrence covenants: restrict M&A, dividends, and additional debt unless tests pass
• Restricted payments and capex baskets: small permitted amounts, with exceptions for sponsor approved transactions
• Financial reporting and material adverse change (MAC) clauses

Best practices

• Stress test covenants under 10-25% EBITDA decline
• Prefer covenant‑lite only with lower pricing and strong sponsor track record
• Stagger debt maturities to avoid a single refinancing cliff
• Negotiate borrower‑friendly baskets (e.g., add‑back flexibility)

One-liner: stress-test covenants aggressively - lenders don't care about your plan if the covenant trips.

Role of sponsor equity and rollover equity

Sponsor equity does three things: pays the difference between debt and price, funds fees and transaction costs, and drives governance and incentives post‑close. Rollover equity is management's retained stake in the new capital structure and aligns management with sponsor returns.

Practical mechanics and considerations

• Sponsor equity check: size to deliver control-commonly 25-40% of purchase price pro‑forma
• Rollover equity: management often retains 5-20% of total equity post‑close; higher rollover signals confidence to lenders and can reduce sponsor cash outlay
• Equity waterfall: define liquidation preference and common equity rights clearly
• Vesting and clawbacks: use to keep management focused on 3-5 year value creation

Tax and negotiation points

• Rollover can be structured as tax‑deferred share exchange - get pre‑close tax opinion
• Sponsor wants board control; management wants upside and downside protection (e.g., earnouts, escrow)
• Document conversion mechanics on exit, IPO, or secondary sale

Actionable steps

• Quantify sponsor IRR target and implied equity multiple before finalizing price
• Model scenarios with management rollover at 10-20% to see alignment effects
• Allocate a small escrow (1-5% of equity) for indemnity and working capital true‑ups

One-liner: use rollover to buy alignment, not to paper over valuation gaps - defintely negotiate the economics hard.

Next step: Finance - build a three‑scenario capital‑stack model (base, downside, upside) showing covenant headroom and rollover impact by Wednesday; owner: you.

Valuation and modeling

You're building an LBO model to decide whether to buy a business, and you need clear inputs, outputs, and sensitivity checks so you can see the range of outcomes quickly. The short takeaway: build a 5‑year, sources-and-uses driven model, test multiple exit multiples and growth paths, and focus on IRR, cash-on-cash, and leverage ratios as your decision gates.

Walk through LBO model inputs and outputs

Start with the situation: historical FY2022-FY2025 financials, then convert to normalized FY2025 run-rate numbers. Use audited revenue, cost of goods sold, SG&A, capex, and working capital trends. Call out one-time items and adjust EBITDA (earnings before interest, taxes, depreciation, and amortization) to a reliable operating EBITDA for FY2025.

Core inputs you must populate before modeling debt:

• Revenue and 3-5 year growth assumptions
• FY2025 EBITDA and margin assumptions
• Capex schedule and depreciation
• Working capital days movement
• Existing gross debt and cash
• Debt terms: types, interest rates, amortization
• Transaction fees, financing fees, and tax rate

Here's the quick math on sources & uses (example, illustrative case using FY2025 run-rate):

• FY2025 EBITDA $85,000,000 (margin ~17%)
• Entry EV/EBITDA multiple 8.0x → Enterprise value $680,000,000
• Existing gross debt $300,000,000, cash $0 → equity purchase price $380,000,000
• New financing: senior term loan $300,000,000, mezzanine $100,000,000, sponsor equity $280,000,000 → total sources $680,000,000
• Uses: repay existing debt $300,000,000, seller equity proceeds $380,000,000

Primary outputs to build after the schedule is complete:

• Levered free cash flow each year
• Debt schedule with opening balance, interest, amortization, closing balance
• Interest expense and cash interest paid
• Available cash for dividends or bolt-on M&A
• Projected exit equity value and investor returns

What this estimate hides: you must reconcile pro forma capex and working capital to industry peers; small changes in days of working capital can swing free cash flow materially, especially early years.

Key metrics to track

Pick a short list of decision metrics and track them every iteration. One-liner: IRR tells you whether the deal clears the return hurdle; leverage and coverage tell you if it's safe to hold.

• Internal rate of return (IRR) - annualized investor return
• Cash-on-cash (multiple of money, MoM) - total cash returned divided by cash invested
• Debt / EBITDA - leverage at entry and projected across the hold
• Interest coverage (EBITDA / cash interest) - short-term debt service buffer
• Debt amortization rate and covenant ratios (fixed charge coverage, total leverage)

Using the example assumptions and a 5-year hold with an exit multiple of 7.0x and exit EBITDA of $120,000,000 (growth + margin work):

• Exit enterprise value = 7.0 × 120 = $840,000,000
• Assume exit net debt = $250,000,000 → exit equity value = $590,000,000
• Sponsor equity in = $280,000,000 → cash-on-cash = ~2.11x
• Annualized IRR ≈ 16.1%
• Initial total debt / FY2025 EBITDA = ~4.7x; senior debt / EBITDA = ~3.5x
• Initial interest expense estimate (senior 7.0%, mezz 10%): interest ≈ $31,000,000, coverage ≈ 2.7x

Best practices:

• Stress test covenant levels (e.g., 4.5x max leverage) and model covenant step-downs
• Report both unlevered IRR (project return ignoring debt effects) and levered IRR
• Show sponsor IRR alongside management rollover returns

Sensitivity analysis and exit assumptions

Sensitivity analysis is how you see whether small input errors kill the deal. One-liner: run a 3×3 grid of exit multiple vs. EBITDA outcome, plus scenario P/L paths for downside, base, and upside.

Concrete steps to run sensitivity analysis:

• Define ranges: exit multiple ±1.0x from base, EBITDA at exit -17%/0/+17%
• Run a 5-year model for each cell and capture exit equity, MoM, IRR
• Highlight scenarios where IRR < sponsor hurdle (e.g., 15%) or covenant breach occurs
• Create a tornado chart ranking input sensitivity by IRR impact

Example sensitivity outputs from the case above (select cells):

• Base: exit multiple 7.0x, exit EBITDA $120m → equity value $590m, IRR 16.1%
• Downside: exit multiple 6.0x, exit EBITDA $100m → equity value $500m, IRR ~ 11.6%
• Upside: exit multiple 8.0x, exit EBITDA $140m → equity value $870m, IRR ~ 25.3%

Practical considerations for exit assumptions:

• Use trailing 12-month and forward EBITDA for multiples
• Check precedent public and private M&A comps within the prior 12 months
• Model alternative exits: strategic sale, IPO, and minority recap
• Include realistic frictional costs: sell-side fees, taxes, transaction expenses (~1-3% of EV)

What to watch for: if IRR is driven mostly by multiple expansion rather than operating cash flow, the investment is sensitive to market timing and therefore defintely higher risk.

Modeling: build the 5-year LBO workbook with an automated sensitivity grid; FP&A: deliver the sensitivity table and covenant heatmap by Friday (owner: Modeling).

Value creation levers

Operational improvements

You want faster margin expansion without breaking the core business; start with diagnostics, then sequence fixes.

Step 1: baseline. Map trailing-12 months revenue, gross margin, SG&A, and working capital. Use waterfall metrics: revenue mix, unit economics, and channel profitability. Step 2: quick wins (0-12 months): renegotiate top 20 supplier contracts, reduce SKU complexity, and cut noncustomer-facing FTEs. Step 3: medium-term (12-36 months): implement pricing orchestration, salesforce productivity tools, and targeted automation in finance and supply chain.

Here's the quick math: on a company with $500,000,000 revenue and a current EBITDA margin of 12% ($60,000,000), raising margin to 18% yields an incremental $30,000,000 EBITDA.

Best practices:

• Benchmark top 3 peers
• Prioritize actions by cash impact
• Track monthly KPI sprints
• Use retention bonuses for critical staff

What this estimate hides: implementation drag, customer churn from price moves, and required capex for automation - plan contingencies.

Financial engineering

Use leverage to amplify equity returns, but manage interest, amortization, and covenant stress up front.

Step 1: set target capital structure. Example illustration: purchase EV $500,000,000 funded with $125,000,000 equity (25%) and $375,000,000 debt (75%). If debt costs 8%, interest = $30,000,000 annually, producing a tax shield at a 21% rate of ~$6,300,000 per year.

Step 2: size tranches-use senior secured for 3-4x EBITDA, mezzanine or PIK for the balance. Insert covenants that allow seasonal swings: covenant headroom = 10-15% of forecasted EBITDA to avoid technical default.

One-liner: leverage helps returns, but refinancing and rate shocks kill mid-cycle equity value.

Best practices:

• Stress-test at +300bp rates
• Model covenant tests quarterly
• Lock a portion of debt as fixed-rate
• Plan an exit-cap strategy year 3-5

What this hides: higher leverage raises default probability and reduces optionality for add-ons.

Strategic moves

Drive value through add-on M&A, smarter pricing, and product‑mix shifts that lift margins sustainably.

Step 1: add-on playbook. Target tuck-ins that deliver 5-15% incremental revenue and 5-8% combined SG&A synergies. Define integration milestones: leadership, IT, procurement, and customer retention metrics.

Step 2: pricing and mix. Run a price elasticity test on 10% of SKUs; a 2% price increase on $300,000,000 revenue adds $6,000,000 revenue - mostly drop-through to EBITDA if incremental cost is low. Reallocate sales incentives to high‑margin SKUs and shift channel mix toward direct or subscription revenues.

One-liner: small, repeatable add-ons plus disciplined pricing often create more value than one large bolt-on.

Best practices:

• Set 90‑day integration sprint
• Measure synergies monthly
• Keep buyer earnouts tied to cash
• Preserve top-customer continuity

Beware overpaying for scale-thin synergies kill returns and defintely slow integration.

Operations: sponsor finance team to draft a 36‑month value creation plan with revenue, margin, capex, and working capital line items by Friday. Finance: build a sensitivity matrix (±200bp margin, ±25% revenue) and share with the investment committee.

Risks, covenants, and downside scenarios

You're running or assessing an LBO that leans on leverage; now map the main downside paths and put clear, prioritized actions against each. The single most important job is to translate credit, operational, and covenant risks into measurable triggers you can act on before they become emergencies.

Credit risk: interest rates, refinancing risk

Interest-rate moves and refinancing timing drive whether the deal survives year 1 or 3. Start with FY2025 base cash flow and debt schedule and stress both rates and liquidity to see where the model breaks.

One clean line: stress rates by +300 basis points and check if EBITDA still covers interest plus scheduled amortization.

• Use FY2025 EBITDA as base
• Test +100/200/300 bps scenarios
• Model 12-36 month refinancing windows
• Build liquidity buffer equal to 6-12 months interest
• Map creditor maturities and covenants

Example quick math: if FY2025 EBITDA = $100,000,000, and your initial debt = $420,000,000 (net leverage ≈ 4.2x), at an all-in rate of 7% interest = $29,400,000. If rates rise to 10%, interest = $42,000,000, dropping interest coverage materially. What this estimate hides: amortization schedules, revolver draws, and FX exposures can increase funding needs quickly.

Practical steps and best practices:

• Lock term sheets on key tranches pre-close
• Push for longer bullet maturities where possible
• Include staggered amortization to avoid clumps
• Size revolver for maximum stress draw
• Negotiate optional rate collars or fixes

Operational failure: customer loss, integration risk

Operational failure is the common path from healthy covenants to default - losing 10-20% of revenue can destroy coverage even if leverage looks ok on paper. Treat operations as a credit hedge: protect cash flow first, growth second.

One clean line: if top-3 customers are >30% revenue, build contingency plans now.

• Quantify customer concentration in FY2025
• Run a downside revenue case (-10%, -20%, -30%)
• Estimate direct margin impact and fixed-cost absorption
• Prioritize short-cycle working capital fixes
• Plan for rapid cost takeout of 3-6 months

Steps to reduce the chance of operational collapse:

• Secure key-customer contracts and extend terms
• Create integration playbook with 30/60/90 day milestones
• Freeze nonessential capex in downside
• Hedge commodity or FX exposures tied to margins
• Set KPIs and daily cash reporting to lenders

Decisions to make early: authorize a $5-15m contingency fund for customer retention in mid-market deals, and require the COO to own the 30/60/90 integration cadence - exec ownership cuts response time, and defintely matters in stress.

Covenant breaches and rescue options

Covenant breaches are operationalized: missed test → lender notice → potential acceleration. Your goal is to avoid that chain or to create a credible rescue plan lenders accept quickly.

One clean line: treat any covenant miss as a 72‑hour crisis with a single owner.

• Map all maintenance and incurrence covenants
• Model covenant sensitivity on FY2025 numbers
• Prepare waiver/amendment playbook pre-close
• Identify likely equity cure sources and limits
• List rapid asset-sale candidates and expected proceeds

Rescue options and practical steps:

• Negotiate waivers early - offer reporting upgrades
• Use equity cures where permitted; quantify max cure
• Seek forbearance and a remediation plan with milestones
• Structure PIK (payment-in-kind) toggles as a bridge
• Prepare sale-accelerator: list 3 assets with pro forma proceeds

Operational playbook for a covenant breach:

• Day 0: CFO notifies lenders, calls creditors
• Day 1-3: deliver 13-week cash and remedial plan
• Day 4-14: negotiate waiver or access DIP/bridge
• Day 15+: execute asset sale or equity cure

Sample negotiation levers: offer tighter reporting, higher fees, reduced distributions, or a temporary EBITDA add-back removal; lenders often prefer structured remediation over costly workouts.

Next step: Finance: draft 13-week cash view using FY2025 assumptions and three downside cases by Friday; CFO owns delivery.

Due diligence and execution checklist

You're sizing up an LBO and need a tight, execution-ready due diligence plan so you don't close on bad cash flow or surprise liabilities.

Direct takeaway: focus commercial checks on durable demand, financial checks on cash conversion and capex tails, and legal checks on contract traps and tax exposures - then assign owners and deadlines. One-liner: cover market, cash, and legal risks before signing.

Commercial diligence: TAM, competition, pricing

Start by framing the addressable market and the company's realistic share. Validate the Total Addressable Market (TAM) with at least two independent sources (industry reports, company-verified customer data) and triangulate growth using a top-down (macro) and bottom-up (customer-level) approach. One-liner: prove the demand curve before you commit capital.

Practical steps and checks:

• Quantify TAM and Serviceable Obtainable Market (SOM) with dated sources (preferably 2023-2025 reports) and show a 3- to 5-year CAGR range.
• Run customer-level interviews: confirm wins, losses, pricing sensitivity, and contract length for the top 20% of revenue accounts.
• Map competitor positioning: price, product gaps, go-to-market channels, and three near-term disruption scenarios.
• Validate pricing power: perform price-elasticity tests or review historical price change passes and margin impact over the last 36 months.
• Segment revenue by customer type, channel, and product; flag any > 10% single-customer concentration as high risk.
• Assess sales efficiency: CAC (customer acquisition cost), payback period, and churn by cohort; target payback < 18 months for B2B SaaS, adjust for industry.

Owner and timing: Commercial team (or market diligence adviser) runs TAM and customer interviews within 14 calendar days; strategy lead delivers a market-risk memo.

Financial diligence: working capital, capex, carve-outs

Translate the commercial story into cash. The financial diligence aims to verify normalized EBITDA, working capital needs, recurring capex, and one-time items that distort free cash flow. One-liner: lock the cash bridge from EBITDA to free cash flow.

Key steps and checks:

• Normalize EBITDA: identify nonrecurring items, owner compensation add-backs, and discretionary spend; produce a normalized P&L for the last 12 months and a trailing 3-year view.
• Working capital analysis: calculate DSO, DPO, and DIO; model working capital as days and as % of revenue. Benchmark targets: aim for near-peer DSO within ± 10 days; highlight seasonal peaks requiring revolver capacity.
• Capex review: split maintenance vs. growth capex; capture multi-year lumps. Use capex as % of revenue benchmarks: services 2-6%, manufacturing 5-12%, tech/platforms higher. Flag any upcoming large projects (>$5m) that need funding.
• Cash conversion cycle sensitivity: stress test a +20% revenue shock and a +50% increase in DSO to see revolver draw and covenant impact.
• Carve-out accounting: identify shared services, allocation keys, and transitional service agreements (TSAs). Quantify incremental standalone costs and capex needs for the first 12 months post-close.
• Tax and deferred items: reconcile tax assets/liabilities and ensure tax attributes survive the deal structure; quantify potential cash tax drag for the first 3 years.
• Prepare a 13-week cash model and a 5-year base and downside case; include a covenant schedule showing headroom under each case.

Owner and timing: Finance leads prepare the 13-week cash and normalized financial model within 10 business days; external accountant completes carve-out P&L and working capital waterfall in parallel.

Legal and tax: contracts, regulatory, indemnities

Legal diligence finds the deal breakers: change-of-control clauses, assignment limits, large indemnities, or regulatory approvals that could stop or delay closing. One-liner: identify contractual landmines and quantify contingent liabilities.

Actionable legal and tax checklist:

• Contract review: extract all material contracts (top 50 revenue and supply agreements). Flag termination-for-cause, change-of-control clauses, assignment restrictions, and renewal mechanics.
• Employment and benefits: list key employee agreements, non-competes, and incentive plans. Quantify severance or retention costs that trigger on change of control.
• Litigation and disputes: summarize pending claims, potential damages, and defense costs. Request litigation reserves and outside counsel opinions.
• Regulatory and licensing: confirm licenses needed to operate in each jurisdiction and timelines for transfers or approvals. Model delay impact if an approval takes > 90 days.
• Tax structuring and exposures: obtain tax opinions on transfer pricing, NOL (net operating loss) utilization, and potential tax liabilities from past transactions. Quantify realistic cash tax rate for the first 3 years post-closing.
• Indemnities and escrows: set indemnity caps, baskets (deductibles), and escrow sizes. Typical market practice: cap at 10-30% of deal equity, escrow of 5-10% of purchase price, and survival 12-36 months depending on risk.
• Environmental and product liability: require Phase I/II environmental reports where applicable and product recall reserves for consumer businesses.
• Data privacy and IP: verify ownership of core IP, third-party licenses, and adequacy of data protection controls (GDPR/CALOPPA considerations if cross-border).

Owner and timing: Legal lead compiles material contracts and an issues memo within 7 business days; tax adviser issues a short-form tax opinion within 14 days. Finance and legal jointly propose escrow and indemnity sizing for negotiation.

Next step: Legal: schedule a contract triage workshop and assign remediation owners within 72 hours (Legal lead).

Conclusion

When LBOs make sense and when to avoid

You want control and clear levers to improve returns; an LBO makes sense when cash flows are predictable, capex needs are moderate, and the business can sustain debt service without aggressive growth assumptions.

One-liner: Pick LBOs where stable cash covers interest and leaves room for investment.

Practical signs to pursue an LBO

• Stable EBITDA with low cyclicality (repeatable revenue).

• Predictable working capital and capex under 5-10% of sales.

• Market positions that allow margin expansion or price increases.

• Exit markets (strategic buyers or IPO window) that support reasonable multiples.

• Management willing to rollover equity and run the business post-close.

When to avoid an LBO

• High revenue volatility or single-customer concentration exceeding 20-30% of sales.

• Heavy, uncertain capex (asset turnarounds, long R&D timelines).

• Regulatory or litigation risk that could impair cash flow quickly.

• Debt markets closed or cost of capital so high debt service consumes >50% of EBITDA.

What this hides: industry norms vary, so test sensitivity to slower cash flow scenarios before closing - defintely stress-test downside.

Decisive indicators for proceeding

Proceed only when quantitative and qualitative indicators align: coverage ratios, leverage, growth visibility, and governance incentives.

One-liner: Let the math and incentives agree before you sign.

Concrete thresholds (rules of thumb)

• Debt/EBITDA post-close generally ≤ 4x for mid-market deals; conservative deals target 3x.

• Interest coverage (EBITDA / cash interest) > 3x.

• Projected free cash flow margin that supports debt amortization and 2-3% organic growth without covenant stress.

• Expected exit multiple within +/- 1.5x of entry multiple in base case sensitivity.

• Management rollover equity at least 10-20% to align incentives.

Best practices

• Run a three-scenario model: base, downside (-20% EBITDA), and upside (+20% EBITDA).

• Require lender commitments or bridge financing terms before binding equity funding.

• Negotiate covenant holiday or flexible amortization in year one.

Next steps for investors and sponsors

Move from decision to execution with precise, time-boxed deliverables that close the information gaps and allocate accountability.

One-liner: Convert analysis into a 30/90/180-day plan with owners.

Immediate actions (first 30 days)

• Finance: draft a 13-week cash view and worst-case liquidity plan by Friday.

• Diligence lead: finalize commercial diligence (TAM, pricing, churn) and deliver report in 10 business days.

• Legal: capture key contract risks and required reps & warranties within 7 business days.

• Operating team: produce a 100-day value capture plan (top 5 initiatives) within 14 days.

Medium-term (30-180 days)

• Negotiate debt docs to limit covenants linked to EBITDA add-backs.

• Lock in vendor and customer transition terms for carve-outs.

• Agree management scorecard and rollover equity mechanics; set milestone-based earnouts if needed.

Risks to monitor and contingency steps

• Interest-rate shock - prepare a refinancing pathway and covenant waiver plan.

• Revenue shortfall - activate cost-out programs and suspend non-essential capex.

• Covenant breach - pre-agree amendment terms or staged equity recap options.

Owner for next step: Sponsor / Deal Lead - finalize term sheet and financing plan within 14 calendar days.